Status:
COMPLETED
Correlation of Plasma Endothelial Cell Activity With Cardiovascular Events in Patients With Diabetes Mellitus Type 2
Lead Sponsor:
US Department of Veterans Affairs
Collaborating Sponsors:
American Diabetes Association
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
40+ years
Brief Summary
CSP 465-B, Correlation of Plasma Endothelial Cell (Basic Fibroblast Growth Factor) Activity With Cardiovascular Events in Patients with Diabetes Mellitus, Type II. Mark Zimering M.D. Objectives: End...
Detailed Description
Primary Hypothesis: The aim of the present study is to investigate whether an angiogenic growth factor, basic fibroblast growth factor (bFGF), plays a role in increased CV risk in type 2 diabetes mell...
Eligibility Criteria
Inclusion
- Patients with type 2 DM who are no longer responsive to maximum dose of one or more oral agents.
Exclusion
- Not a part of the VADT.
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00252525
Start Date
June 1 2007
End Date
May 1 2008
Last Update
June 27 2014
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Carl T. Hayden VA Medical Center
Phoenix, Arizona, United States, 85012
2
VA Medical Center, Long Beach
Long Beach, California, United States, 90822
3
Miami VA Healthcare System, Miami, FL
Miami, Florida, United States, 33125
4
VA Medical Center, Omaha
Omaha, Nebraska, United States, 68105-1873